| Biomarkers for Early Detection of Clinically Relvant Prostate Cancer: A Multi-Institutional Validation Trial - Genomic Health, Inc. |
1 |
0 |
| Development of a novel, urine-based molecular assay for prediction of progression, recurrence, and need for definitive therapy on active surveillance for prostate cancer |
0 |
0 |
| Discovery of novel genomic classifiers for improved management of active surveillance patients |
0 |
0 |
| Evaluating SelectMDx for the prediction of high-grade prostate cancer in men with low-grade prostate cancer on active surveillance in the Canary Prostate Active Surveillance Study (PASS) |
0 |
0 |
| Evaluation of emerging tissue-based biomarkers for aggressive prostate cancer in men on active surveillance |
0 |
0 |
| Germline Genetic Variants and Faliure of Acitve Sureveillance |
0 |
0 |
| Investigating Circulating Metabolism-Related Biomarkers and Diet in an Active Surveillance Population |
0 |
0 |
| PASS Reference Set Application: Lin Univ. of Washington/OncoChip (2013) |
0 |
0 |
| PASS Reference Set Application: Lin Univ. of Washington/OPKO (2015) |
1 |
0 |
| Prostate Active Surveillance Study |
2 |
0 |
| Upgrading Reference Set |
0 |
0 |
